Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ultrasound vs. endoscope: which is better for detecting swallowing trouble after ICU?

NCT ID NCT07734298

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study tests whether a simple bedside ultrasound can reliably detect swallowing problems in patients who have just had a breathing tube removed in the ICU. Researchers will compare ultrasound findings with those from a standard endoscopic exam (FEES) in 40 adults. If ultrasound proves accurate, it could become a faster, less invasive screening tool for post-extubation dysphagia.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If ultrasound proves reliable, it could offer a quicker, non-invasive way to screen for swallowing problems in ICU patients, reducing the need for uncomfortable endoscopy.
What could go wrong
This is a small, early-stage study with only 40 participants. Ultrasound may not be accurate enough to replace the gold-standard endoscopy, and results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Critically ill patients admitted to the Intensive Care Unit (ICU). * Patients aged 18 years or older. * Patients who have required orotracheal intubation and mechanical ventilation for a period exceeding 48 hours. * Patients successfully liberated from mechanical ventilation (post-extubation phase). * Obtainment of signed Informed Consent from the patient or their legal representative. Exclusion Criteria: * Patients with a known prior history of oropharyngeal dysphagia, esophageal disorders, or structural abnormalities of the upper airway. * Patients with pre-existing neurological diseases that compromise the swallowing reflex (e.g., advanced Parkinson's disease, previous stroke with residual dysphagia, Amyotrophic Lateral Sclerosis). * Patients with a history of head and neck surgery or radiotherapy. * Patients with a Glasgow Coma Scale (GCS) score \< 13 at the time of evaluation. * Patients with hemodynamic instability or severe respiratory distress that precludes the diagnostic procedures. * Anatomical limitations that prevent the correct placement of the ultrasound transducer or the introduction of the nasofibroscope (e.g., severe facial trauma, nasal obstruction). * Medical contraindication for Fiberoptic Endoscopic Evaluation of Swallowing (FEES).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aspiration are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Deglutition Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital H+

    RECRUITING

    Querétaro City, Querétaro, 7600, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.